Idhifa (Celgene Corporation)
Welcome to the PulseAid listing for the Idhifa drug offered from Celgene Corporation. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Celgene Corporation |
| NON-PROPRIETARY NAME: | enasidenib mesylate |
| SUBSTANCE NAME: | ENASIDENIB MESYLATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2017-08-01 |
| END MARKETING DATE: | 0000-00-00 |
Idhifa HUMAN PRESCRIPTION DRUG Details:
| Item Description | Idhifa from Celgene Corporation |
| LABELER NAME: | Celgene Corporation |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 50(mg/1) |
| START MARKETING DATE: | 2017-08-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 59572-705_6cd3975b-7970-4c9a-a5e5-f0510bf0d770 |
| PRODUCT NDC: | 59572-705 |
| APPLICATION NUMBER: | NDA209606 |
Other ENASIDENIB MESYLATE Pharmaceutical Manufacturers / Labelers:
